236 related articles for article (PubMed ID: 27328499)
1. Expression and clinical significance of tumor markers in ovarian mature cystic teratoma.
Chen JM; Gao HY; Wang Q; Li Q
Clin Exp Obstet Gynecol; 2016; 43(3):397-400. PubMed ID: 27328499
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostic value of multiple tumor marker detection for mature and immature teratoma of the ovary].
Chen C; Li JD; Huang H; Feng YL; Wang LH; Chen L
Ai Zheng; 2008 Jan; 27(1):92-5. PubMed ID: 18184473
[TBL] [Abstract][Full Text] [Related]
3. Do high levels of CA 19-9 in women with mature cystic teratomas of the ovary warrant further evaluation?
Ugur MG; Ozturk E; Balat O; Dikensoy E; Teke S; Aydin A
Eur J Gynaecol Oncol; 2012; 33(2):207-10. PubMed ID: 22611965
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the importance of the serum levels of CA-125, CA15-3, CA-19-9, carcinoembryonic antigen and alpha fetoprotein for distinguishing benign and malignant adnexal masses and contribution of different test combinations to diagnostic accuracy.
Bozkurt M; Yumru AE; Aral I
Eur J Gynaecol Oncol; 2013; 34(6):540-4. PubMed ID: 24601047
[TBL] [Abstract][Full Text] [Related]
5. Tumor markers in mature cystic teratomas of the ovary.
Ustunyurt E; Gungor T; Iskender C; Ustunyurt BO; Bilge U; Mollamahmutoglu L
Arch Gynecol Obstet; 2009 Feb; 279(2):145-7. PubMed ID: 18506458
[TBL] [Abstract][Full Text] [Related]
6. Retrospective evaluation of tumor markers in ovarian mature cystic teratoma and ovarian endometrioma.
Kataoka T; Watanabe Y; Hoshiai H
J Obstet Gynaecol Res; 2012 Aug; 38(8):1071-6. PubMed ID: 22568880
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic value of carcinoembryonic antigen, alpha fetoprotein, carbohydrate antigen 125 and carbohydrate antigen 19-9 in gastroenteropancreatic neuroendocrine neoplasms].
Chen L; Zhang Y; Chen M; Chen J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1002-1008. PubMed ID: 28900990
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer.
Feng F; Tian Y; Xu G; Liu Z; Liu S; Zheng G; Guo M; Lian X; Fan D; Zhang H
BMC Cancer; 2017 Nov; 17(1):737. PubMed ID: 29121872
[TBL] [Abstract][Full Text] [Related]
9. Application of Joint Detection of AFP, CA19-9, CA125 and CEA in Identification and Diagnosis of Cholangiocarcinoma.
Li Y; Li DJ; Chen J; Liu W; Li JW; Jiang P; Zhao X; Guo F; Li XW; Wang SG
Asian Pac J Cancer Prev; 2015; 16(8):3451-5. PubMed ID: 25921161
[TBL] [Abstract][Full Text] [Related]
10. Significant simultaneous changes in serum CA19-9 and CA125 due to prolonged torsion of mature cystic teratoma of the ovary.
Suh DS; Moon SH; Kim SC; Joo JK; Park WY; Kim KH
World J Surg Oncol; 2014 Nov; 12():353. PubMed ID: 25416055
[TBL] [Abstract][Full Text] [Related]
11. CA19-9 elevation in ovarian mature cystic teratoma: discrimination from ovarian cancer - CA19-9 level in teratoma.
Cho HY; Kim K; Jeon YT; Kim YB; No JH
Med Sci Monit; 2013 Mar; 19():230-5. PubMed ID: 23539074
[TBL] [Abstract][Full Text] [Related]
12. Use of cancer antigen 125, cancer antigen 19-9, and the neutrophil-to-lymphocyte ratio to diagnose mature cystic teratoma with torsion.
Wang YQ; Xia WT; Wang F; Zhuang XX; Zheng FY; Lin F
Int J Gynaecol Obstet; 2017 Jun; 137(3):332-337. PubMed ID: 28273351
[TBL] [Abstract][Full Text] [Related]
13. The reference intervals for CA125, CA15-3, CA19-9, CA72-4, AFP, CEA, NSE and CYFRA21-1.
Yang J; Tang A; Ma J; Sun X; Ming L
Scand J Clin Lab Invest; 2019; 79(1-2):71-74. PubMed ID: 30727773
[TBL] [Abstract][Full Text] [Related]
14. The clinical significance of CA19-9 in ovarian mature cystic teratoma.
Fan JT; Yan HQ; Malla S; Fan YJ; Xu H; Li DH; Liu Y
Clin Exp Obstet Gynecol; 2016; 43(4):522-525. PubMed ID: 29734540
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of mature teratomas containing malignant elements.
Hirai K; Ishiko O; Itoh F; Nakagawa E; Kanaoka Y; Sumi T; Ogita S
Oncol Rep; 2000; 7(3):655-7. PubMed ID: 10767385
[TBL] [Abstract][Full Text] [Related]
16. Elevated CA 19-9 levels in mature cystic teratoma of the ovary.
Kyung MS; Choi JS; Hong SH; Kim HS
Int J Biol Markers; 2009; 24(1):52-6. PubMed ID: 19404923
[TBL] [Abstract][Full Text] [Related]
17. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Value of Tumor Markers].
Nyangoh-Timoh K; Bendifallah S; Dion L; Ouldamer L; Levêque J
Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):277-286. PubMed ID: 32004789
[TBL] [Abstract][Full Text] [Related]
18. CA19-9 may have clinical significance in mature cystic teratomas of the ovary.
Dede M; Gungor S; Yenen MC; Alanbay I; Duru NK; Haşimi A
Int J Gynecol Cancer; 2006; 16(1):189-93. PubMed ID: 16445632
[TBL] [Abstract][Full Text] [Related]
19. Preoperative determination of several serum tumor markers in patients with primary epithelial ovarian carcinoma.
Kudoh K; Kikuchi Y; Kita T; Tode T; Takano M; Hirata J; Mano Y; Yamamoto K; Nagata I
Gynecol Obstet Invest; 1999; 47(1):52-7. PubMed ID: 9852392
[TBL] [Abstract][Full Text] [Related]
20. Effect of the coronavirus pandemic on tumor markers.
Purut YE; Giray B; Gurbuz E
J Med Virol; 2021 Sep; 93(9):5405-5408. PubMed ID: 33932304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
